BAP1 and miR-31 combination predicts outcome in epithelioid malignant pleural mesothelioma

被引:0
|
作者
Pecci, F. [1 ]
Cantini, L. [2 ]
Cognigni, V. [1 ]
Murrone, A. [1 ]
Monaco, F. [3 ]
Rubini, C. [4 ]
Barbisan, F. [4 ]
Copparoni, C. [1 ]
Rinaldi, S. [1 ]
Fiordoliva, I. [1 ]
Paolo, M. Di Pietro [1 ]
Scarpelli, M. [4 ]
Tomasetti, M. [3 ]
Santarelli, L. [3 ]
Berardi, R. [1 ]
机构
[1] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I, GM Lancisi, Clin Oncol,G Salesi, Ancona, Italy
[2] Univ Politecn Marche, Clin Oncol, Ancona, Italy
[3] Dipartimento Sci Clin & Mol, Med Lavoro, Ancona, Italy
[4] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Umberto I, Anat Patol, GM Lancisi,G Salesi, Ancona, Italy
关键词
D O I
10.1016/j.annonc.2020.08.1448
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1905P
引用
收藏
页码:S1080 / S1080
页数:1
相关论文
共 50 条
  • [41] Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications
    Forest, Fabien
    Patoir, Arnaud
    Dal Col, Pierre
    Sulaiman, Abdulrazzaq
    Camy, Florian
    Laville, David
    Bayle-Bleuez, Sophie
    Fournel, Pierre
    Habougit, Cyril
    PATHOLOGY, 2018, 50 (06) : 635 - 641
  • [42] Combined Use of p16 FISH and Bap1 Immunohistochemistry Optimizes Diagnosis of Malignant Pleural Mesothelioma
    McGregor, S. M.
    Minor, A.
    Fitzpatrick, C.
    Husain, A. N.
    Hyjek, E.
    Vigneswaran, W.
    Krausz, T.
    MODERN PATHOLOGY, 2013, 26 : 460A - 460A
  • [43] Somatic BAP1 Loss as a Predictive Biomarker of Overall Survival in Patients With Malignant Pleural Mesothelioma Treated With Chemotherapy
    Ghafoor, Azam
    Hassan, Raffit
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (07) : 862 - 864
  • [44] Diagnostic application of BAP1 immunohistochemistry to differentiate pleural mesothelioma from metastatic pleural tumours
    Yoshimura, Masayo
    Kinoshita, Yoshiaki
    Hamasaki, Makoto
    Matsumoto, Shinji
    Hida, Tomoyuki
    Oda, Yoshinao
    Nabeshima, Kazuki
    HISTOPATHOLOGY, 2017, 71 (06) : 1011 - 1014
  • [45] Combined Use of p16 FISH and Bap1 Immunohistochemistry Optimizes Diagnosis of Malignant Pleural Mesothelioma
    McGregor, S. M.
    Minor, A.
    Fitzpatrick, C.
    Husain, A. N.
    Hyjek, E.
    Vigneswaran, W.
    Krausz, T.
    LABORATORY INVESTIGATION, 2013, 93 : 460A - 460A
  • [46] Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Hellmann, Matthew David
    Borsu, Laetitia
    Zehir, Ahmet
    Cheng, Donavan T.
    Zha, Zheng
    Siegel, Beth
    Rohrer, Rebecca W.
    Robson, Mark E.
    Arnold, Angela G.
    Fleischut, Megan Harian
    Cavatore, Magali
    Gaskeil, Alice A.
    Gawel, Craig
    Robertson, Alexander
    Viale, Agnes
    Rusch, Valerie W.
    Krug, Lee M.
    Ladanyi, Marc
    Zauderer, Marjorie Glass
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma
    Nasu, Masaki
    Pastorino, Sandra
    Luk, Hugh
    Flores, Erin
    Baumann, Francine
    Powers, Amy
    Kanodia, Shreya
    Gaudino, Giovanni
    Zhang, Yu-an
    Gazdar, Adi
    Yang, Haining
    Pass, Harvey I.
    Emi, Mitsuru
    Carbone, Michele
    CANCER RESEARCH, 2015, 75
  • [48] BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
    Alakus, Hakan
    Yost, Shawn E.
    Woo, Brian
    French, Randall
    Lin, Grace Y.
    Jepsen, Kristen
    Frazer, Kelly A.
    Lowy, Andrew M.
    Harismendy, Olivier
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [49] BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
    Harismendy, Olivier
    Alakus, Hakan
    Yost, Shawn
    Woo, Brian
    French, Randall
    Lin, Grace Y.
    Jepsen, Kristen
    Frazer, Kelly A.
    Lowy, Andrew M.
    CANCER RESEARCH, 2015, 75
  • [50] BAP1 loss in malignant mesothelioma: distribution according the histological subtype
    Martin Lopez, J.
    Martin Acosta, P.
    Salas Anton, C.
    VIRCHOWS ARCHIV, 2020, 477 : S121 - S122